SPHERA FUNDS MANAGEMENT LTD.
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 1496201
TEL AVIV, L3
Position in TEVA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$34,245,687
-$819,528 QoQ
Shares Held
1,136,975
+1.2% QoQ
Ownership
0.098%
of shares outstanding
% of Portfolio
5.96%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Derivatives in TEVA
reported options exposure · as of Jun 30, 2024CallValue
$53,119,625
CallShares
3,268,900
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026SPHERA FUNDS MANAGEMENT LTD. holds $45,311,123 across 4 Drug Manufacturers - Specialty & Generic names. TEVA ranks #1 (75.6% of the industry book) .
All Filings in TEVA
Export CSV
36 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $34,245,687 | 1,136,975 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $35,065,215 | 1,123,525 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $30,441,905 | 1,507,025 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $27,167,792 | 1,620,990 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $24,164,421 | 1,572,181 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $34,584,749 | 1,569,181 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $38,386,492 | 2,130,216 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $53,119,625 | 3,268,900 | Call | Defined | 2024-08-14 | |
| 2024-06-30 | $12,828,010 | 789,416 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $44,202,397 | 3,132,700 | Call | Defined | 2024-05-15 | |
| 2024-03-31 | $26,663,667 | 1,889,700 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $13,404,960 | 1,284,000 | Call | Defined | 2024-02-15 | |
| 2023-12-31 | $25,777,404 | 2,469,100 | Shares | Defined | 2024-02-15 | |
| 2023-09-30 | $6,120,000 | 600,000 | Shares | Defined | 2023-11-14 | |
| 2023-09-30 | $51,140,760 | 5,013,800 | Call | Defined | 2023-11-14 | |
| 2023-06-30 | $61,329,591 | 8,144,700 | Call | Defined | 2023-08-14 | |
| 2023-06-30 | $7,906,500 | 1,050,000 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $18,049,575 | 2,039,500 | Shares | Defined | 2023-05-15 | |
| 2023-03-31 | $18,027,450 | 2,037,000 | Call | Defined | 2023-05-15 | |
| 2022-09-30 | $6,265,112 | 776,346 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $8,632,042 | 1,147,878 | Shares | Defined | 2022-08-15 | |
| 2022-06-30 | $25,429,632 | 3,381,600 | Call | Defined | 2022-08-15 | |
| 2022-03-31 | $17,747,100 | 1,890,000 | Call | Defined | 2022-05-16 | |
| 2022-03-31 | $1,971,900 | 210,000 | Put | Defined | 2022-05-16 | |
| 2022-03-31 | $7,820,724 | 832,878 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $6,671,344 | 832,877 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $10,227,000 | 1,050,000 | Call | Defined | 2021-11-15 | |
| 2021-09-30 | $8,112,231 | 832,878 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $18,909,000 | 1,910,000 | Call | Defined | 2021-08-17 | |
| 2021-06-30 | $8,245,492 | 832,878 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $10,256,752 | 888,800 | Call | Defined | 2021-05-17 | |
| 2021-03-31 | $9,611,412 | 832,878 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $8,037,272 | 832,878 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $14,261,730 | 1,582,878 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $7,186,885 | 582,878 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $3,203,282 | 356,713 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||